The Renal Activity Index for Lupus Identifies Active Renal Disease and Treatment Response in Adult Patients With Systemic Lupus Erythematosus and Lupus Nephritis. Arthritis Care and Research. 2026; 78(6):723-732.
Metabolomic investigation of cisplatin-induced acute kidney injury in paediatric cancer patients. British Journal of Clinical Pharmacology. 2026; e70587.
Difference of Admission Neutrophil Gelatinase-Associated Lipocalin Concentration Between Patients Developing and Not Developing Acute Kidney Injury or Need for Acute Dialysis: An Ancillary Individual-Study Data Meta-Analysis (INDICATE-AKI). Kidney Medicine. 2026; 8(5):101280.
The Renal Activity Index for Lupus: Validation for Prediction of Kidney Inflammation in Adult Patients With Lupus Nephritis. Journal of Rheumatology. 2026; 53(3):283-291.
Dietary intervention in medically complex stone forming children with enteric hyperoxaluria. Journal of Pediatric Urology. 2025; 21(6):1420-1425.
Urine Olfactomedin 4 Predicts Furosemide Response and Kidney Replacement Therapy in Critically Ill Children. Critical Care Explorations. 2025; 7(12):e1356.
Defining subgroups of pediatric nephrotic patients with urine proteomics. Scientific Reports. 2025; 15(1):25064.
Pediatric Nephrology Practice in the United States: Survey of Pediatric Nephrology Division Directors. American Journal of Kidney Diseases. 2025; 86(1):74-83.
Volumetric Absorptive Microsampling Combined with Mass Spectrometry to Support Pharmacokinetically-Guided Precision Dosing of Mycophenolate Mofetil in Pediatric Lupus Nephritis Patients. Journal of Applied Laboratory Medicine. 2025; 10(4):806-819.
Development and Validation of Multiplex Assays for Lupus Nephritis Activity Biomarkers. Kidney International Reports. 2025; 10(7):2255-2264.
Alkaline urine is associated with increased risk of calcium phosphate nephrolithiasis in medically complex children receiving enteral nutrition. Journal of Pediatric Urology. 2025; 21(3):591-597.
Prolonged unilateral renal ischemia-reperfusion as a model for acute to chronic kidney injury in female mice. American Journal of Physiology - Renal Physiology. 2025; 328(5):F684-F690.
Gucy1α1 specifically marks kidney, heart, lung and liver fibroblasts. Scientific Reports. 2024; 14(1):29307.
Tubular Injury Biomarkers to Predict CKD and Hypertension at 3 Months Post-Cisplatin in Children. Kidney360. 2024; 5(6):821-833.
Plasma renin as a novel prognostic biomarker of sepsis-associated acute respiratory distress syndrome. Scientific Reports. 2024; 14(1):6667.
A proposed framework for advancing acute kidney injury risk stratification and diagnosis in children: a report from the 26th Acute Disease Quality Initiative (ADQI) conference. Pediatric Nephrology. 2024; 39(3):929-939.
Advances in pediatric acute kidney injury pathobiology: a report from the 26th Acute Disease Quality Initiative (ADQI) conference. Pediatric Nephrology. 2024; 39(3):941-953.
Pediatric AKI in the real world: changing outcomes through education and advocacy-a report from the 26th Acute Disease Quality Initiative (ADQI) consensus conference. Pediatric Nephrology. 2024; 39(3):1005-1014.
Fluid assessment, fluid balance, and fluid overload in sick children: a report from the Pediatric Acute Disease Quality Initiative (ADQI) conference. Pediatric Nephrology. 2024; 39(3):955-979.
Programs and processes for advancing pediatric acute kidney support therapy in hospitalized and critically ill children: a report from the 26th Acute Disease Quality Initiative (ADQI) consensus conference. Pediatric Nephrology. 2024; 39(3):993-1004.
Advances in pediatric acute kidney injury pharmacology and nutrition: a report from the 26th Acute Disease Quality Initiative (ADQI) consensus conference. Pediatric Nephrology. 2024; 39(3):981-992.
Epidemiology of acute kidney injury in children: a report from the 26th Acute Disease Quality Initiative (ADQI) consensus conference. Pediatric Nephrology. 2024; 39(3):919-928.
Single-cell sequencing dissects the transcriptional identity of activated fibroblasts and identifies novel persistent distal tubular injury patterns in kidney fibrosis. Scientific Reports. 2024; 14(1):439.
Urinary TIMP-2*IGFBP-7 to diagnose acute kidney injury in children receiving cisplatin. Pediatric Nephrology. 2024; 39(1):269-282.
Association of COVID-19 Versus COVID-19 Vaccination With Kidney Function and Disease Activity in Primary Glomerular Disease: A Report of the Cure Glomerulonephropathy Study. American Journal of Kidney Diseases. 2024; 83(1):37-46.
Evaluation of diagnostic accuracy of urine neutrophil gelatinase-associated lipocalin in patients with symptoms of urinary tract infections: a meta-analysis. Frontiers in Pediatrics. 2024; 12:1368583.
Efficacy and Safety of Pharmacokinetically-Driven Dosing of Mycophenolate Mofetil for the Treatment of Pediatric Proliferative Lupus Nephritis-A Double-Blind Placebo Controlled Clinical Trial (The Pediatric Lupus Nephritis Mycophenolate Mofetil Study). Journal of Clinical Trials. 2024; 14(4).
Vigorous Exercise. In: Nelson Textbook of Pediatrics Volume 1 2. 2024:3218-3218.e2.
Vascular Abnormalities. In: Nelson Textbook of Pediatrics Volume 1 2. 2024:3211-3212.e1.
Tubulointerstitial Nephritis. In: Nelson Textbook of Pediatrics Volume 1 2. 2024:3205-3210.e1.
Trauma. In: Nelson Textbook of Pediatrics Volume 1 2. 2024:3213-3217.e2.
Toxic Nephropathy. In: Nelson Textbook of Pediatrics Volume 1 2. 2024:3196-3204.e2.
Sickle Cell Nephropathy. In: Nelson Textbook of Pediatrics Volume 1 2. 2024:3211-3212.e1.
Renal Vein Thrombosis. In: Nelson Textbook of Pediatrics Volume 1 2. 2024:3211-3212.e1.
Pyelonephritis. In: Nelson Textbook of Pediatrics Volume 1 2. 2024:3205-3210.e1.
Papillary Necrosis. In: Nelson Textbook of Pediatrics Volume 1 2. 2024:3205-3210.e1.
Infectious Causes of Cystitis and Urethritis. In: Nelson Textbook of Pediatrics Volume 1 2. 2024:3218-3218.e2.
Autosomal Recessive Polycystic Kidney Disease. In: Nelson Textbook of Pediatrics Volume 1 2. 2024:3213-3217.e2.
Acute Tubular Necrosis. In: Nelson Textbook of Pediatrics Volume 1 2. 2024:3205-3210.e1.
Acute Kidney Injury. In: Nelson Textbook of Pediatrics Volume 1 2. 2024:3242-3253.e1.
IgA Vasculitis Nephritis. In: Nelson Textbook of Pediatrics Volume 1 2. 2024:3196-3204.e2.
Idiopathic Hypercalciuria. In: Nelson Textbook of Pediatrics Volume 1 2. 2024:3211-3212.e1.
Hemorrhagic Cystitis. In: Nelson Textbook of Pediatrics Volume 1 2. 2024:3218-3218.e2.
Hemolytic-Uremic Syndrome. In: Nelson Textbook of Pediatrics Volume 1 2. 2024:3196-3204.e2.
Goodpasture Disease. In: Nelson Textbook of Pediatrics Volume 1 2. 2024:3196-3204.e2.
Glomerulonephritis Associated with Systemic Lupus Erythematosus. In: Nelson Textbook of Pediatrics Volume 1 2. 2024:3196-3204.e2.
Cortical Necrosis. In: Nelson Textbook of Pediatrics Volume 1 2. 2024:3196-3204.e2.
Congenital Anomalies. In: Nelson Textbook of Pediatrics Volume 1 2. 2024:3213-3217.e2.
Coagulopathies and Thrombocytopenia. In: Nelson Textbook of Pediatrics Volume 1 2. 2024:3196-3204.e2.
Chronic Infections. In: Nelson Textbook of Pediatrics Volume 1 2. 2024:3196-3204.e2.
Analysis of the human kidney transcriptome and plasma proteome identifies markers of proximal tubule maladaptation to injury. Science Translational Medicine. 2023; 15(726):eade7287.
COL4A gene variants are common in children with hematuria and a family history of kidney disease. Pediatric Nephrology. 2023; 38(11):3625-3633.
External Validation of a Urinary Biomarker Risk Score for the Prediction of Steroid Responsiveness in Adults With Nephrotic Syndrome. Kidney International Reports. 2023; 8(11):2458-2468.
Single-Cell Sequencing Identifies Novel Activated Fibroblast Marker, Distal Spatial Tubular Injury Pattern, and Functionally Significant Nephrogenic Program Reactivation in Adult AKI-to-CKD Transition. Journal of the American Society of Nephrology. 2023; 34(11S):699-700.
Acute kidney injury biomarker olfactomedin 4 predicts furosemide responsiveness. Pediatric Nephrology. 2023; 38(9):3153-3161.
Urine biomarker score captures response to induction therapy with lupus nephritis. Pediatric Nephrology. 2023; 38(8):2679-2688.
Biomarkers of eGFR decline after cardiac surgery in children: findings from the ASSESS-AKI study. Pediatric Nephrology. 2023; 38(8):2851-2860.
Age of Onset and Disease Course in Biopsy-Proven Minimal Change Disease: An Analysis From the Cure Glomerulonephropathy Network. American Journal of Kidney Diseases. 2023; 81(6):695-706.e1.
Pathogenesis of intrinsic acute kidney injury. Current Opinion in Pediatrics. 2023; 35(2):234-238.
MP10-02 DIETARY INTERVENTION IN ENTERIC HYPEROXALURIA. Investigative Urology. 2023; 209(Supplement 4):e114.
Acute Kidney Injury: Pathophysiology, Diagnosis and Prevention. In: Pediatric Kidney Disease. Springer Nature; 2023:1365-1411.
Enteral nutrition and the risk of nephrolithiasis in complex pediatric patients. Journal of Pediatric Urology. 2022; 18(6):743.e1-743.e6.
A Murine Model of Veno-Arterial Extracorporeal Membrane Oxygenation. ASAIO Journal. 2022; 68(12):e243-e250.
Insights Into Urinary Renin in AKI. Journal of the American Society of Nephrology. 2022; 33(11S):56-57.
Single-Cell Transcriptomic Profiling of Kidney Fibrosis Identifies a Novel Fibroblast Marker and Putative Disease Target. Journal of the American Society of Nephrology. 2022; 33(11S):591-592.
Stability of Novel Urinary Biomarkers Used for Lupus Nephritis. Journal of the American Society of Nephrology. 2022; 33(11S):961-962.
Olfactomedin 4 as a Loop of Henle-Specific AKI Biomarker That Predicts Furosemide Response. Journal of the American Society of Nephrology. 2022; 33(11S):72-72.
Choline supplementation attenuates experimental sepsis-associated acute kidney injury. American Journal of Physiology - Renal Physiology. 2022; 323(3):F255-F271.
Olfactomedin 4 as a novel loop of Henle-specific acute kidney injury biomarker. Physiological Reports. 2022; 10(18):e15453.
Consensus-Based Recommendations on Priority Activities to Address Acute Kidney Injury in Children: A Modified Delphi Consensus Statement. JAMA Network Open. 2022; 5(9):e2229442.
Human Stem Cell and Organoid Models to Advance Acute Kidney Injury Diagnostics and Therapeutics. International Journal of Molecular Sciences. 2022; 23(13).
The KIDNEYCODE Program: Diagnostic Yield and Clinical Features of Individuals with CKD. Kidney360. 2022; 3(5):900-909.
Candidate Biomarkers for Sepsis-Associated Acute Kidney Injury Mechanistic Studies. Shock. 2022; 57(5):687-693.
Multiparametric quantitative renal MRI in children and young adults: comparison between healthy individuals and patients with chronic kidney disease. Abdominal Radiology. 2022; 47(5):1840-1852.
Clinical measurement of lupus nephritis activity is inferior to biomarker-based activity assessment using the renal activity index for lupus nephritis in childhood-onset systemic lupus erythematosus. Lupus Science and Medicine. 2022; 9(1).
Emerging Role of Clinical Genetics in CKD. Kidney Medicine. 2022; 4(4):100435.
NGAL/hepcidin-25 ratio and AKI subtypes in patients following cardiac surgery: a prospective observational study. Journal of Nephrology. 2022; 35(2):597-605.
International Consensus for the Dosing of Corticosteroids in Childhood-Onset Systemic Lupus Erythematosus With Proliferative Lupus Nephritis. Arthritis & Rheumatology. 2022; 74(2):263-273.
Urine Neutrophil Gelatinase-Associated Lipocalin and Kidney Injury Molecule-1 to Detect Pediatric Cisplatin-Associated Acute Kidney Injury. Kidney360. 2022; 3(1):37-50.
Renin Kinetics Are Superior to Lactate Kinetics for Predicting In-Hospital Mortality in Hypotensive Critically Ill Patients. Critical Care Medicine. 2022; 50(1):50-60.
Stability of novel urinary biomarkers used for lupus nephritis. Frontiers in Pediatrics. 2022; 10:974049.